<DOC>
	<DOCNO>NCT02612610</DOCNO>
	<brief_summary>This 12-week , randomize , parallel , double-blind , placebo-controlled study AF-219 subject refractory chronic cough .</brief_summary>
	<brief_title>A 12-Week Study Subjects With Refractory Chronic Cough</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<criteria>Women Men 18 80 year age inclusive Have refractory chronic cough Women childbearing potential must use 2 form acceptable birth control Have provide write informed consent . Are willing able comply aspect protocol Current smoker FEV1/FVC &lt; 60 % History upper low respiratory tract infection recent significant change pulmonary status within 4 week Baseline Visit History opioid use within 1 week Baseline Visit Body mass index ( BMI ) &lt; 18 kg/m2 â‰¥ 40 kg/m2 History concurrent malignancy recurrence malignancy within 2 year prior Screening ( include subject &lt; 3 excise basal cell carcinoma ) Screening systolic blood pressure ( SBP ) &gt; 160 mm Hg diastolic blood pressure ( DBP ) &gt; 90 mm Hg Clinically significant abnormal electrocardiogram ( ECG ) Screening Significantly abnormal laboratory test Screening Pregnant Breastfeeding Other severe , acute , chronic medical psychiatric condition laboratory abnormality may increase risk associate trial participation investigational product administration may interfere interpretation trial result , judgment Investigator Sponsor , would make subject inappropriate entry trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>